Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Public ClinicalTrials.gov record NCT00196404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure urge incontinence, urinary urgency and elevated urinary frequency
Study identification
- NCT ID
- NCT00196404
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 800 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2004 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Dec 2006 (Actual)
- Last update posted
- Aug 20, 2012
2004 – 2006
United States locations
- U.S. sites
- 46
- U.S. states
- 24
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duramed Investigational Site | Birmingham | Alabama | 35209 | — |
| Duramed Investigational Site | Huntsville | Alabama | 35801 | — |
| Duramed Investigational Site | Mobile | Alabama | 36608 | — |
| Duramed Research Site | Phoenix | Arizona | 85015 | — |
| Duramed Research Site | Tucson | Arizona | 85712 | — |
| Duramed Investigational Site | Little Rock | Arkansas | 72205 | — |
| Duramed Investigational Site | San Diego | California | 92108 | — |
| Duremed Research Site | San Diego | California | 92108 | — |
| Duramed Investigational Site | Aurora | Colorado | 80012 | — |
| Duramed Research Site | Colorado Springs | Colorado | 80909 | — |
| Duramed Investigational Site | Denver | Colorado | 80220 | — |
| Duramed Investigational Site | Waterbury | Connecticut | 06708 | — |
| Duramed Investigational Site | Aventura | Florida | 33180 | — |
| Duramed Research Site | Gainesville | Florida | 32607 | — |
| Duramed Investigational Site | Decatur | Georgia | 30034 | — |
| Duramed Research Site | Sandy Springs | Georgia | 30328 | — |
| Duramed Investigational Site | Boise | Idaho | 83712 | — |
| Duramed Investigational Site | Boise | Indiana | 83705 | — |
| Duramed Investigational Site | Evansville | Indiana | 47714 | — |
| Duramed Investigational Site | Fort Wayne | Indiana | 46825 | — |
| Duramed Investigational Site | Indianapolis | Indiana | 46202 | — |
| Duramed Investigational Site | Jeffersonville | Indiana | 47130 | — |
| Duramed Investigational Site | Meridian | Indiana | 83642 | — |
| Duramed Investigational Site | Shreveport | Louisiana | 71106 | — |
| Duramed Investigational Site | Jackson | Mississippi | 39202 | — |
| Duramed Investigational Site | Lebanon | New Hampshire | 03756 | — |
| Duramed Investigational Site | Edison | New Jersey | 08837 | — |
| Duramed Investigational Site | Livingston | New Jersey | 07039 | — |
| Duramed Investigational Site | Moorestown | New Jersey | 08057 | — |
| Duramed Investigational Site | Williamsville | New York | 14221 | — |
| Duramed Investigational Site | Portland | Oregon | 97210 | — |
| Duramed Investigational Site | Lancaster | Pennsylvania | 17604 | — |
| Duramed Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Duramed Investigational Site | Providence | Rhode Island | 02904 | — |
| Duramed Investigational Site | Charleston | South Carolina | 29425 | — |
| Duramed Investigational Site | Jackson | Tennessee | 38305 | — |
| Duramed Investigational Site | Memphis | Tennessee | 38120 | — |
| Duramed Investigational Site | Nashville | Tennessee | 37232 | — |
| Duramed Investigational Site | Dallas | Texas | 75234 | — |
| Duramed Research Site | Houston | Texas | 77024 | — |
| Duramed Investigational Site | San Antonio | Texas | 78229 | — |
| Duramed Research Site | Waco | Texas | 76712 | — |
| Duramed Investigational Site | Salt Lake City | Utah | 84124 | — |
| Duramed Investigational Site | Seattle | Washington | 98105 | — |
| Duramed Research Site | Tacoma | Washington | 98405 | — |
| Duramed Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00196404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2012 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00196404 live on ClinicalTrials.gov.